Managing Bronchiolitis and Respiratory Syncytial Virus: Finding the Yellow Brick Road

Archives of Pediatrics and Adolescent Medicine

Volumn 158, Issue 2, 2004, Pages 111-112

  Hall, Caroline Breese ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; RESPIRATORY SYNCYTIAL VIRUS VACCINE; RIBAVIRIN;

BRONCHIOLITIS; CHILD; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; EDITORIAL; HUMAN; IMMUNIZATION; INFANT; INFECTION CONTROL; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIROLOGY; VIRUS INFECTION; WHEEZING;

ANTIVIRAL AGENTS; BRONCHIOLITIS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFANT; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RIBAVIRIN;

EID: 0842333161     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.158.2.111     Document Type: Editorial

References (19)

1. Bordley WC, Viswanathan M, King VJ, et al. Diagnosis and testing in bronchiolitis: a systematic review. Arch Pediatr Adolesc Med. 2004;158:119-126.
2. King VJ, Viswanathan M, Bordley WC, et al. Pharmacologic treatment of bronchiolitis in infants and children: a systematic review. Arch Pediatr Adolesc Med. 2004;158:127-137.
3. Gardson M, Christakis O, Harvey E, et al. Systemic corticosteroids in infant bronchiolitis: a meta-analysis. Pediatrics. 2000;105:e44.
4. Martinello R, Chen M, Weibel C, et al. Correlation between respiratory syncytial genotype and severity of illness. J Infect Dis. 2002;186:939-842.
5. Hull J, Thomson A, Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax. 2000;55:1023-1027.
6. Lofgren J, Ramet M, Renko M, et al. Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants. J Infect Dis. 2002;185:283-289.
7. Lahti M, Lofgren J, Marttila R, et al. Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection. Pediatr Res. 2002;51:696-699.
8. Hoebee B, Rietveld E, Bont L, et al. Association of severe respiratory syncytial virus bronchiolitis with interleukin-4 and interleukin-4 receptor alpha polymorphisms. J Infect Dis. 2003;187:2-11.
9. Choi E, Lee H, Yoo T, et al. A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. J Infect Dis. 2002;186:1207-1211.
10. Adams JM. A third epidemic of primary virus pneumonitis among infants in Minnesota. Lancet. 1945;65:192-193.
11. Bonville C, Rosenberg H, Domachowshe J. Successful therapeutic intervention for severe bronchiolitis using pharmacologic blockade of chemokine receptor-1 (CCR1) in combination with antiviral therapy. Paper presented at: Annual Meeting of the Pediatric Academic Societies; May 3, 2003; Seattle, Wash.
12. Domachowske J, Rosenberg H. Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. Clin Microbiol Rev 1999;12:298-309.
13. Torrence P, Powell L. The quest for an efficacious antiviral for respiratory syncytial virus. Antivir Chem Chemomother. 2002;13:325-344.
14. Openshaw P, Dean G, Culley F. Links between respiratory syncytial virus bronchiolitis and childhood asthma: clinical and research approaches. Pediatr Infect Dis J. 2003;22:S58-S65.
15. Meissner HC, Long SS, and the American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics. 2003;112(suppl 6, pt 1):1447-1452.
16. Hall C. Respiratory syncytial virus infections in previously healthy working adults. Clin Infect Dis. 2001;33:792-796.
17. Falsey A, Walsh E. Respiratory syncytial virus infections in adults. Clin Microbiol Rev. 2000;13:371-384.
18. Crowe JE Jr. Respiratory syncytial virus vaccine development. Vaccine. 2001;20:S32-S37.
19. Collins P, Murphy B. Respiratory syncytial virus: reverse geriatrics and vaccine strategies. Virology 2002;296:204-211.